<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: No immunity for Dendreon&#8217;s cancer vaccine</title>
	<atom:link href="http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 20:47:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Are there any effective treatments for advanced prostate cancer? &#124; Prostate Nutrition Blog</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-829412</link>
		<dc:creator>Are there any effective treatments for advanced prostate cancer? &#124; Prostate Nutrition Blog</dc:creator>
		<pubDate>Wed, 24 Sep 2008 17:55:12 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-829412</guid>
		<description>[...] No immunity for Dendreon&#8217;s cancer vaccine - dendreon-logo.jpg For almost two months, it has seemed that the FDA might be ready to approve an entirely new attack on cancer &#8212; a &#8220;cancer vaccine&#8221; that immunizes patients with tumor fragments in order to activate the body&#8217;s immune &#8230;        addthis_url = &#039;http%3A%2F%2Fprostatenutrition.ruqqa.com%2Fprostate-treatments%2Fare-there-any-effective-treatments-for-advanced-prostate-cancer&#039;; addthis_title = &#039;Are+there+any+effective+treatments+for+advanced+prostate+cancer%3F&#039;; addthis_pub = &#039;&#039;; [...]</description>
		<content:encoded><![CDATA[<p>[...] No immunity for Dendreon&rsquo;s cancer vaccine &#8211; dendreon-logo.jpg For almost two months, it has seemed that the FDA might be ready to approve an entirely new attack on cancer &mdash; a &ldquo;cancer vaccine&rdquo; that immunizes patients with tumor fragments in order to activate the body&rsquo;s immune &#8230;        addthis_url = &#8216;http%3A%2F%2Fprostatenutrition.ruqqa.com%2Fprostate-treatments%2Fare-there-any-effective-treatments-for-advanced-prostate-cancer&#8217;; addthis_title = &#8216;Are+there+any+effective+treatments+for+advanced+prostate+cancer%3F&#8217;; addthis_pub = &#8221;; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: janc</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-800288</link>
		<dc:creator>janc</dc:creator>
		<pubDate>Wed, 26 Mar 2008 09:43:30 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-800288</guid>
		<description>Health Answerer
www.healthanswerer.com</description>
		<content:encoded><![CDATA[<p>Health Answerer<br />
<a href="http://www.healthanswerer.com" rel="nofollow">http://www.healthanswerer.com</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: janc</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-800287</link>
		<dc:creator>janc</dc:creator>
		<pubDate>Wed, 26 Mar 2008 09:42:08 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-800287</guid>
		<description>Disease Conditions
www.gedisease.com</description>
		<content:encoded><![CDATA[<p>Disease Conditions<br />
<a href="http://www.gedisease.com" rel="nofollow">http://www.gedisease.com</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: janc</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-800286</link>
		<dc:creator>janc</dc:creator>
		<pubDate>Wed, 26 Mar 2008 09:40:01 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-800286</guid>
		<description>cancer
www.cancerqa.com</description>
		<content:encoded><![CDATA[<p>cancer<br />
<a href="http://www.cancerqa.com" rel="nofollow">http://www.cancerqa.com</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: janc</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-800285</link>
		<dc:creator>janc</dc:creator>
		<pubDate>Wed, 26 Mar 2008 09:39:13 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-800285</guid>
		<description>health living
www.comchen.com</description>
		<content:encoded><![CDATA[<p>health living<br />
<a href="http://www.comchen.com" rel="nofollow">http://www.comchen.com</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Bellicum&#8217;s prostate-cancer vaccine: Dendritic cells served with a genetic twist</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-576144</link>
		<dc:creator>VentureBeat &#187; Bellicum&#8217;s prostate-cancer vaccine: Dendritic cells served with a genetic twist</dc:creator>
		<pubDate>Fri, 12 Oct 2007 21:52:17 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-576144</guid>
		<description>[...] iffy data supporting its effectiveness. The fate of Provenge now hangs in the balance following the FDA&#8217;s controversial decision to ask for additional data. But that hasn&#8217;t stopped Bellicum Pharmaceuticals from trying to [...]</description>
		<content:encoded><![CDATA[<p>[...] iffy data supporting its effectiveness. The fate of Provenge now hangs in the balance following the FDA&#8217;s controversial decision to ask for additional data. But that hasn&#8217;t stopped Bellicum Pharmaceuticals from trying to [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Wednesday, Oct. 10, 2007</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-572448</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Wednesday, Oct. 10, 2007</dc:creator>
		<pubDate>Wed, 10 Oct 2007 18:35:43 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-572448</guid>
		<description>[...] the body&#8217;s own immune-system defenses against tumors. (Dendreon, whose Provenge vaccine has been in the news over the past several months, is taking a similar approach.) The new wrinkle in Bellicum&#8217;s [...]</description>
		<content:encoded><![CDATA[<p>[...] the body&#8217;s own immune-system defenses against tumors. (Dendreon, whose Provenge vaccine has been in the news over the past several months, is taking a similar approach.) The new wrinkle in Bellicum&#8217;s [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Weekend update: That cold, cold artificial heart, Dendreon-related skulduggery, congressional earmarks, and more</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-420996</link>
		<dc:creator>VentureBeat &#187; Weekend update: That cold, cold artificial heart, Dendreon-related skulduggery, congressional earmarks, and more</dc:creator>
		<pubDate>Mon, 13 Aug 2007 14:42:25 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-420996</guid>
		<description>[...] critical of Dendreon&#8217;s cancer vaccine Provenge, which we&#8217;ve written about at length here and here. (The FDA asked Dendreon for more Provenge data, despite the previous endorsement of its [...]</description>
		<content:encoded><![CDATA[<p>[...] critical of Dendreon&#8217;s cancer vaccine Provenge, which we&#8217;ve written about at length here and here. (The FDA asked Dendreon for more Provenge data, despite the previous endorsement of its [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Roundup: Biogenerics bill in limbo, clashing data on health IT benefits, the RNAi boom, and more</title>
		<link>http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/comment-page-1/#comment-401676</link>
		<dc:creator>VentureBeat &#187; Roundup: Biogenerics bill in limbo, clashing data on health IT benefits, the RNAi boom, and more</dc:creator>
		<pubDate>Fri, 10 Aug 2007 23:58:30 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/05/09/no-immunity-for-dendreons-cancer-vaccine/#comment-401676</guid>
		<description>[...] not, although it&#8217;s also worth noting that a reconsideration still wouldn&#8217;t have helped Dendreon&#8217;s Provenge vaccine, since its survival data was so statistically equivocal. (Separately, the SEC has now opened an [...]</description>
		<content:encoded><![CDATA[<p>[...] not, although it&#8217;s also worth noting that a reconsideration still wouldn&#8217;t have helped Dendreon&#8217;s Provenge vaccine, since its survival data was so statistically equivocal. (Separately, the SEC has now opened an [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
